Human medicines European public assessment report (EPAR): Fiasp, insulin aspart, Diabetes Mellitus, Date of authorisation: 09/01/2017, Revision: 2, Status: Authorised

Human medicines European public assessment report (EPAR): Fiasp, insulin aspart, Diabetes Mellitus, Date of authorisation: 09/01/2017, Revision: 4, Status: Authorised

Case Medical Research ◽

10.31525/cmr-c3f2b0 ◽

2019 ◽

Author(s):

Keyword(s):

Diabetes Mellitus ◽

Insulin Aspart ◽

Assessment Report ◽

European Public ◽

European Public Assessment Report

Download Full-text

Human medicines European public assessment report (EPAR): Ryzodeg, insulin degludec / insulin aspart, Diabetes Mellitus, Date of authorisation: 21/01/2013, Revision: 11, Status: Authorised

Case Medical Research ◽

10.31525/cmr-191b085 ◽

2019 ◽

Author(s):

Keyword(s):

Diabetes Mellitus ◽

Insulin Aspart ◽

Insulin Degludec ◽

Assessment Report ◽

European Public ◽

European Public Assessment Report

Download Full-text

Human medicines European public assessment report (EPAR): Ryzodeg, insulin degludec / insulin aspart, Diabetes Mellitus, Date of authorisation: 20/01/2013, Revision: 10, Status: Authorised

Case Medical Research ◽

10.31525/cmr-399694 ◽

2018 ◽

Author(s):

Keyword(s):

Diabetes Mellitus ◽

Insulin Aspart ◽

Insulin Degludec ◽

Assessment Report ◽

European Public ◽

European Public Assessment Report

Download Full-text

Human medicines European public assessment report (EPAR): NovoRapid, insulin aspart, Diabetes Mellitus, Date of authorisation: 07/09/1999, Revision: 29, Status: Authorised

Case Medical Research ◽

10.31525/cmr-c4dbaf ◽

2019 ◽

Author(s):

Keyword(s):

Diabetes Mellitus ◽

Insulin Aspart ◽

Assessment Report ◽

European Public ◽

European Public Assessment Report

Download Full-text

Human medicines European public assessment report (EPAR): NovoMix, insulin aspart, Diabetes Mellitus, Date of authorisation: 01/08/2000, Revision: 27, Status: Authorised

Case Medical Research ◽

10.31525/cmr-1a59719 ◽

2019 ◽

Author(s):

Keyword(s):

Diabetes Mellitus ◽

Insulin Aspart ◽

Assessment Report ◽

European Public ◽

European Public Assessment Report

Download Full-text

Human medicines European public assessment report (EPAR): NovoRapid, insulin aspart, Diabetes Mellitus, Date of authorisation: 07/09/1999, Revision: 30, Status: Authorised

Case Medical Research ◽

10.31525/cmr-c3f2b2 ◽

2019 ◽

Author(s):

Keyword(s):

Diabetes Mellitus ◽

Insulin Aspart ◽

Assessment Report ◽

European Public ◽

European Public Assessment Report

Download Full-text

Human medicines European public assessment report (EPAR): Insuman, insulin human, Diabetes Mellitus, Date of authorisation: 21/02/1997, Revision: 27, Status: Authorised

Case Medical Research ◽

10.31525/cmr-133690d ◽

2019 ◽

Author(s):

Keyword(s):

Diabetes Mellitus ◽

Assessment Report ◽

European Public ◽

Human Diabetes ◽

European Public Assessment Report

Download Full-text

Human medicines European public assessment report (EPAR): Xiliarx, vildagliptin, Diabetes Mellitus, Type 2, Date of authorisation: 19/11/2008, Revision: 16, Status: Authorised

Case Medical Research ◽

10.31525/cmr-3996de ◽

2018 ◽

Author(s):

Keyword(s):

Diabetes Mellitus ◽

Diabetes Mellitus Type 2 ◽

Diabetes Mellitus Type ◽

Assessment Report ◽

European Public ◽

European Public Assessment Report

Download Full-text

Human medicines European public assessment report (EPAR): Invokana, canagliflozin, Diabetes Mellitus, Type 2, Date of authorisation: 15/11/2013, Revision: 13, Status: Authorised

Case Medical Research ◽

10.31525/cmr-116dee6 ◽

2019 ◽

Author(s):

Keyword(s):

Diabetes Mellitus ◽

Diabetes Mellitus Type 2 ◽

Diabetes Mellitus Type ◽

Assessment Report ◽

European Public ◽

European Public Assessment Report

Download Full-text

Human medicines European public assessment report (EPAR): Qtrilmet, metformin hydrochloride / saxagliptin / dapagliflozin, Diabetes Mellitus, Type 2, Date of authorisation: 11/11/2019, Status: Authorised

Case Medical Research ◽

10.31525/cmr-23f0dba ◽

2019 ◽

Author(s):

Keyword(s):

Diabetes Mellitus ◽

Diabetes Mellitus Type 2 ◽

Diabetes Mellitus Type ◽

Metformin Hydrochloride ◽

Assessment Report ◽

European Public ◽

European Public Assessment Report

Download Full-text